Literature DB >> 1933057

Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation.

S Morio1, H Oh, A Hirasawa, N Aotsuka, H Nakamura, T Asai, S Yoshida, M Ito.   

Abstract

A 37-year-old man with acute myeloblastic leukemia (FAB M2) in first remission underwent a bone marrow transplant (BMT) following conditioning with high-dose cytarabine and total body irradiation. The donor was an HLA-identical brother. Graft rejection occurred and a second BMT was performed from the same donor following conditioning with cyclophosphamide. Engraftment was achieved, but the patient developed severe jaundice and died of respiratory failure on day +46 after the second BMT. Liver biopsy revealed luminal narrowing of the central veins and a diagnosis of hepatic veno-occlusive disease (VOD) was made. The coagulation studies showed a prolonged kaolin clotting time which was not corrected by 1:1 mixture with normal plasma, and the platelet neutralization test was positive. Dilute tissue thromboplastin time and dilute Russell viper venom time were also prolonged. These results fulfilled the criteria for lupus anticoagulant, which may have contributed to VOD in this patient.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933057

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

Review 1.  The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies.

Authors:  Jin Zhang; Cheng Li; Xiaorong Han; Zhongbo Chen; Binay Kumar Adhikari; Yinghui Wang; Yonggang Wang; Jian Sun
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 2.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

3.  Bilateral Adrenal Hemorrhage in a Patient with Antiphospholipid Syndrome during Chronic Graft-versus-host Disease.

Authors:  Mariko Minami; Tsuyoshi Muta; Masahiro Adachi; Masakazu Higuchi; Kenichi Aoki; Ryosuke Ogawa
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

Review 4.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.